ARTICLE | Company News
Cellectar Biosciences, Pierre Fabre Group deal
January 4, 2016 8:00 AM UTC
The companies partnered non-exclusively to co-design a library of small molecule-drug conjugate products combining Cellectar’s phospholipid drug conjugate platform with cytotoxics from Pierre Fabre to...